Sponsor:
Baylor Research Institute
Code:
NCT05371756
Conditions
Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Cancer
Study ID
NCT05371756
Start date
Sep 11, 2020
Status verified date
Mar, 2026
Completion date
Sep 11, 2050
Anticipated
Primary completion date
Sep 11, 2035
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
10000 participants
Anticipated
Arms
Surgical
Immunotherapy
Primary outcome measure
Central contacts
Locations
Baylor Scott & White Medical Center - College Station
Recruiting
College Station, Texas, United States, 77845
Contacts
Baylor University Medical Center - Dallas
Recruiting
Dallas, Texas, United States, 75246
Contacts
Principal Investigator:
Ronan J Kelly, MD, MBA
Baylor Scott & White All Saints Medical Center - Fort Worth
Recruiting
Fort Worth, Texas, United States, 76104
Contacts
Baylor Scott & White Medical Center - Plano
Recruiting
Plano, Texas, United States, 75093
Contacts
Baylor Scott & White Medical Center - Round Rock
Recruiting
Round Rock, Texas, United States, 78665
Contacts
Baylor Scott & White Medical Center - Temple
Recruiting
Temple, Texas, United States, 76508
Contacts
Baylor Scott & White Medical Center - Hillcrest
Recruiting
Waco, Texas, United States, 76712
Contacts
Baylor Scott & White Medical Center - Waxahachie
Recruiting
Waxahachie, Texas, United States, 75165
Contacts
Sponsor
Baylor Research Institute
Last update posted
Mar 16, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Baylor Research Institute on 2026-03-16.